Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. (Q37603879)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 March 2016
edit
Language Label Description Also known as
English
Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.
scientific article published on 29 March 2016

    Statements

    Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit